Raghu Rao
Chief Executive Officer, Director · Sonnet BioTherapeutics Holdings, Inc.
Individual
- 2024
- Dec 3, 2025
- 3
Other insiders active in the same sector
No other insider has filed at Raghu Rao's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
- David Cordani - $60.11M in CI purchases and sales in the last 12 months
- AI DMI LLC - $59.87M in IRON purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Raghu Rao?
Raghu Rao is a corporate insider, tracked as Chief Executive Officer, Director of Sonnet BioTherapeutics Holdings, Inc. (SONN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Raghu Rao last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 3 filings going back to 2024.
